Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

The recently suggested intestinal cancer stem cell markerDCLK1is an epigenetic biomarker for colorectal cancer

(2014) Hege Marie Vedeld et al.   Epigenetics

The novel colorectal cancer biomarkersCDO1, ZSCAN18andZNF331are frequently methylated across gastrointestinal cancers

(2014) Hege Marie Vedeld et al.   INTERNATIONAL JOURNAL OF CANCER

Vimentin in Upper Gastrointestinal Pathologies--Letter

(2012) G. E. Lind et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies

(2012) H. Moinova et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Beyond cytomorphology: Expanding the diagnostic potential for biliary cytology

(2012) Barbara E. Chadwick   DIAGNOSTIC CYTOPATHOLOGY

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

(2012) Kim Andresen et al.   Epigenetics

Inflammation-Associated Cancer Development in Digestive Organs: Mechanisms and Roles for Genetic and Epigenetic Modulation

(2012) Tsutomu Chiba et al.   GASTROENTEROLOGY

Bile-Based Detection of Extrahepatic Cholangiocarcinoma with Quantitative DNA Methylation Markers and Its High Sensitivity

(2012) So-Hyun Shin et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Primary sclerosing cholangitis and malignancy

(2011) Kirsten Muri Boberg et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Cancer epigenetics: linking basic biology to clinical medicine

(2011) Hsing-Chen Tsai et al.   CELL RESEARCH

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma

(2011) Emmanouil Sinakos et al.   Clinical Gastroenterology and Hepatology

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

(2011) Guro E Lind et al.   Molecular Cancer

SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis

(2011) G E Lind et al.   ONCOGENE

Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples

(2010) V. L. Costa et al.   CLINICAL CANCER RESEARCH

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer

(2009) T. deVos et al.   CLINICAL CHEMISTRY

CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma

(2009) Baek-hui Kim et al.   VIRCHOWS ARCHIV

DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease

(2008) Mansour A. Parsi et al.   Clinical Gastroenterology and Hepatology

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis

(2008) Phunchai Charatcharoenwitthaya et al.   HEPATOLOGY

Hypermethylated MAL gene – a silent marker of early colon tumorigenesis

(2008) Guro E Lind et al.   Journal of Translational Medicine

Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer

(2008) Paul P Anglim et al.   Molecular Cancer

DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening

(2007) C. Lofton-Day et al.   CLINICAL CHEMISTRY